Philips Recalled CPAP, Bi-Level PAP, and Mechanical Ventilator

This docket consolidates claims arising from the 2021 recall of sound-abatement foam used in millions of Philips CPAP, BiPAP, and mechanical ventilator devices, after the foam was found to degrade and potentially release particulates and chemical compounds into the airstream patients breathe during use. With 624 actions still pending against 1,033 total filed as of the JPML's September 2026 report, roughly three in five originally filed actions remain active — a docket well past its formation phase but still carrying substantial live inventory, consistent with a matter that resolved a large economic-loss track separately from an ongoing personal-injury track.

The economic-loss claims — seeking the cost of a recalled device that could no longer be used as intended — moved through a negotiated class settlement and device-replacement program relatively early in the litigation's history, which meaningfully narrows what remains fundable on that theory today. The personal-injury track is a different question: claims allege that foam degradation caused respiratory injury or contributed to certain cancers, and those claims carry the underwriting profile of a classic mass tort — diagnosis timing, device model and usage duration, and causation evidence tying a specific injury to foam exposure are the central diligence items, since no bellwether verdict or global settlement framework yet exists to anchor pricing.

Medical-lien exposure is significant and should be modeled early for any personal-injury claim in this docket, particularly where treatment involves cancer care or ongoing respiratory monitoring, since insurers and providers will have real claims against any eventual recovery. For a law firm holding a portfolio of personal-injury claims tied to specific device models and exposure periods, inventory finance under Criterica Capital's mass tort finance line is the applicable structure, though terms should reflect that this docket has not yet reached a settlement or bellwether-verdict phase for the injury track. A structural brief on this docket's dual-track history is available through Criterica Intelligence for firms sorting economic-loss exposure from live personal-injury inventory.

Pre-settlement funding is a non-recourse purchase of a portion of the proceeds of a pending legal claim — not a loan. If the case does not result in a recovery, nothing is owed. Rates, fees, and repayment terms are disclosed in full in the funding agreement, which the applicant’s attorney reviews before signing. Availability and terms vary by state.